Biblio

Author Title Type [ Year(Desc)]
Filters: Author is Wang, Qi  [Clear All Filters]
2021
Liu X, Sun Q, Wang Q, Hu C, Chen X, Li H, Czajkowsky DM, Shao Z. Epithelial Cells in 2D and 3D Cultures Exhibit Large Differences in Higher-order Genomic Interactions. Genomics Proteomics Bioinformatics. 2021.
Chen K, Zhuang Z, Wang Q, Li K, Xu S, Liu M, Zhang K, Wei L, Zhang Y, Lian H, et al. Establishment of TUSMi009-A, an induced pluripotent stem cell (iPSC) line from a 24-year-old Chinese Han patient with gliocytoma. Stem Cell Res. 2021;56:102546.
Hui Y, Jin D, Leng J, Liu D, Yuan P, Tang C, Wang Q. Hsa_circ_0007059 sponges miR-421 to repress cell growth and stemness in hepatocellular carcinoma by the PTEN-AKT/mTOR pathway. Pathol Res Pract. 2021;229:153692.
Pang J, Yang H, Feng X, Wang Q, Cai Y, Liu Z, Wang C, Wang F, Zhang Y. HT-2 toxin affects cell viability of goat spermatogonial stem cells through AMPK-ULK1 autophagy pathways. Theriogenology. 2021;164:22-30.
Gao M, Yu Z, Yao D, Qian Y, Wang Q, Jia R. Mesenchymal stem cells therapy: A promising method for the treatment of uterine scars and premature ovarian failure. Tissue Cell. 2021;74:101676.
Liu F, Wang N, Wang Q, Shan H. Motif mutations in pseudoknot stem I upstream of start codon in Senecavirus A genome: Impacts on activity of viral IRES and on rescue of recombinant virus. Vet Microbiol. 2021;262:109223.
Wang Q, Chear S, Wing K, Stellon D, Tran MThuan Nguy, Talbot J, Pébay A, Hewitt AW, Cook AL. Use of CRISPR/Cas ribonucleoproteins for high throughput gene editing of induced pluripotent stemcells. Methods. 2021.

Pages